GRP and breast carcinoma: The bombesin ligand actively targeted gastrin-releasing peptide receptors (GRPr) on T-47D breast cancer cells, resulting in increased tumor uptake in PET/CT imaging and favorable tumor-to-background ratios, highlighting their utility in GRPr-targeted imaging.